Phase I trial of the positron-emitting Arg-Gly-Asp (RGD) peptide radioligand 18F-AH111585 in breast cancer patients. (2008)

First Author: Kenny LM
Attributed to:  Molecular Therapy funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.2967/jnumed.107.049452

PubMed Identifier: 18483090

Publication URI: http://europepmc.org/abstract/MED/18483090

Type: Journal Article/Review

Volume: 49

Parent Publication: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Issue: 6

ISSN: 0161-5505